Week in review: Cannabis drops, TearCare touchup, not-so-smart phones

This week, a cannabis-based eyedrop for glaucoma is poised for first-in-human trials, reapplying a TearCare treatment prolongs relief for patients with dry eye and uncalibrated smart phones raise the risk of misdiagnosing eye conditions.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553